120 related articles for article (PubMed ID: 28368524)
21. A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases.
Zrubka Z; Beretzky Z; Hermann Z; Brodszky V; Gulácsi L; Rencz F; Baji P; Golicki D; Prevolnik-Rupel V; Péntek M
Eur J Health Econ; 2019 Jun; 20(Suppl 1):119-132. PubMed ID: 31104218
[TBL] [Abstract][Full Text] [Related]
22. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.
Wolfe F; Michaud K; Wallenstein G
J Rheumatol; 2010 Aug; 37(8):1615-25. PubMed ID: 20551106
[TBL] [Abstract][Full Text] [Related]
23. Valuations of EQ-5D health states: are the United States and United Kingdom different?
Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
[TBL] [Abstract][Full Text] [Related]
24. EQ-5D-3L derived population norms for health related quality of life in Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA
PLoS One; 2014; 9(11):e108434. PubMed ID: 25365171
[TBL] [Abstract][Full Text] [Related]
25. Health utility reporting in chronic rhinosinusitis patients.
Bewick J; Morris S; Hopkins C; Erskine S; Philpott CM
Clin Otolaryngol; 2018 Feb; 43(1):90-95. PubMed ID: 28498517
[TBL] [Abstract][Full Text] [Related]
26. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries.
Janssen MF; Szende A; Cabases J; Ramos-Goñi JM; Vilagut G; König HH
Eur J Health Econ; 2019 Mar; 20(2):205-216. PubMed ID: 29445941
[TBL] [Abstract][Full Text] [Related]
27. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Operative Treatment for Adult Cervical Deformity: A Prospective Multicenter Assessment With 1-Year Follow-up.
Ailon T; Smith JS; Shaffrey CI; Kim HJ; Mundis G; Gupta M; Klineberg E; Schwab F; Lafage V; Lafage R; Passias P; Protopsaltis T; Neuman B; Daniels A; Scheer JK; Soroceanu A; Hart R; Hostin R; Burton D; Deviren V; Albert TJ; Riew KD; Bess S; Ames CP;
Neurosurgery; 2018 Nov; 83(5):1031-1039. PubMed ID: 29281107
[TBL] [Abstract][Full Text] [Related]
29. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the EuroQOL-5D with the Oswestry Disability Index, back and leg pain scores in patients with degenerative lumbar spine pathology.
Mueller B; Carreon LY; Glassman SD
Spine (Phila Pa 1976); 2013 Apr; 38(9):757-61. PubMed ID: 23124265
[TBL] [Abstract][Full Text] [Related]
31. Establishing utility values for the 22-item Sino-Nasal Outcome Test (SNOT-22) using a crosswalk to the EuroQol-five-dimensional questionnaire-three-level version (EQ-5D-3L).
Crump RT; Lai E; Liu G; Janjua A; Sutherland JM
Int Forum Allergy Rhinol; 2017 May; 7(5):480-487. PubMed ID: 28182331
[TBL] [Abstract][Full Text] [Related]
32. EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis.
Remenschneider AK; Scangas G; Meier JC; Gray ST; Holbrook EH; Gliklich RE; Metson R
Laryngoscope; 2015 May; 125(5):1056-61. PubMed ID: 25431320
[TBL] [Abstract][Full Text] [Related]
33. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
34. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
Park SJ; Ahn S; Woo SJ; Park KH
JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
[TBL] [Abstract][Full Text] [Related]
35. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
Kiadaliri AA; Eliasson B; Gerdtham UG
Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
[TBL] [Abstract][Full Text] [Related]
36. Cost and quality of life outcome analysis of postoperative infections after subaxial dorsal cervical fusions.
Kuhns BD; Lubelski D; Alvin MD; Taub JS; McGirt MJ; Benzel EC; Mroz TE
J Neurosurg Spine; 2015 Apr; 22(4):381-6. PubMed ID: 25615630
[TBL] [Abstract][Full Text] [Related]
37. A comparative analysis of the prevalence and characteristics of cervical malalignment in adults presenting with thoracolumbar spine deformity based on variations in treatment approach over 2 years.
Jalai CM; Passias PG; Lafage V; Smith JS; Lafage R; Poorman GW; Diebo B; Liabaud B; Neuman BJ; Scheer JK; Shaffrey CI; Bess S; Schwab F; Ames CP;
Eur Spine J; 2016 Aug; 25(8):2423-32. PubMed ID: 27076049
[TBL] [Abstract][Full Text] [Related]
38. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
Pickard AS; Gooderham M; Hartz S; Nicolay C
J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
[TBL] [Abstract][Full Text] [Related]
39. Application of EQ-5D-5L questionnaire in patients suffering from urinary incontinence.
Garcia-Gordillo MA; Collado-Mateo D; Olivares PR; Adsuar JC
Actas Urol Esp; 2016 Sep; 40(7):457-62. PubMed ID: 26975979
[TBL] [Abstract][Full Text] [Related]
40. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
